Prognostic Implications of PET-Derived Tumor Volume and Uptake in Patients with Neuroendocrine Tumors.
NET
PET
SUV
somatostatin receptor
tumor volume
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
12 Jul 2023
12 Jul 2023
Historique:
received:
16
05
2023
revised:
20
06
2023
accepted:
22
06
2023
medline:
29
7
2023
pubmed:
29
7
2023
entrez:
29
7
2023
Statut:
epublish
Résumé
Historically, molecular imaging of somatostatin receptor (SSTR) expression in patients with neuroendocrine tumors (NET) was performed using SSTR scintigraphy (SRS). Sustained advances in medical imaging have led to its gradual replacement with SSTR positron-emission tomography (SSTR-PET). The higher sensitivity in comparison to SRS on the one hand and conventional cross-sectional imaging, on the other hand, enables more accurate staging and allows for image quantification. In addition, in recent years, a growing body of evidence has assessed the prognostic implications of SSTR-PET-derived prognostic biomarkers for NET patients, with the aim of risk stratification, outcome prognostication, and prediction of response to peptide receptor radionuclide therapy. In this narrative review, we give an overview of studies examining the prognostic value of advanced SSTR-PET-derived (semi-)quantitative metrics like tumor volume, uptake, and composite metrics. Complementing this analysis, a discussion of the current trends, clinical implications, and future directions is provided.
Identifiants
pubmed: 37509242
pii: cancers15143581
doi: 10.3390/cancers15143581
pmc: PMC10377105
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
Lancet. 2020 Apr 11;395(10231):1208-1216
pubmed: 32209449
Invest Radiol. 2013 May;48(5):273-9
pubmed: 23493121
J Nucl Med. 2019 Sep;60(9):1266-1269
pubmed: 30850506
J Nucl Med. 2013 Jun;54(6):855-60
pubmed: 23516312
J Nucl Med. 2010 Jun;51(6):875-82
pubmed: 20484441
AJR Am J Roentgenol. 2018 Aug;211(2):267-277
pubmed: 29975116
Mol Imaging. 2022 Mar 17;2022:6511179
pubmed: 35368455
Eur J Endocrinol. 2004 Jul;151(1):15-27
pubmed: 15248818
Ann Surg. 2010 Nov;252(5):850-6
pubmed: 21037441
Ann Nucl Med. 2009 Oct;23(8):745-51
pubmed: 19784877
J Clin Oncol. 2016 Feb 20;34(6):588-96
pubmed: 26712231
Eur Radiol. 2011 Nov;21(11):2408-16
pubmed: 21750886
J Nucl Med. 2021 Oct;62(10):1406-1414
pubmed: 33579805
EJNMMI Res. 2020 Jun 15;10(1):63
pubmed: 32542576
BMC Cancer. 2020 Apr 16;20(1):326
pubmed: 32299391
Eur J Nucl Med. 2000 Mar;27(3):273-82
pubmed: 10774879
Neuroendocrinology. 2009;90(2):220-6
pubmed: 19713714
Neoplasia. 2017 Dec;19(12):991-1002
pubmed: 29091800
Prostate. 2022 May;82(7):826-835
pubmed: 35286735
J Nucl Med. 2016 Jan;57(1):34-40
pubmed: 26471695
Nucl Med Commun. 2020 Apr;41(4):363-369
pubmed: 31977752
J Nucl Med. 1992 May;33(5):652-8
pubmed: 1349039
J Nucl Med. 2010 May;51(5):669-73
pubmed: 20395323
Pathol Int. 2022 Oct;72(10):488-495
pubmed: 35983917
Clin Cancer Res. 2012 May 15;18(10):2838-49
pubmed: 22461457
Expert Rev Anticancer Ther. 2018 Sep;18(9):837-860
pubmed: 29973077
Mol Imaging Biol. 2015 Jun;17(3):313-8
pubmed: 25319765
Clin Nucl Med. 2010 May;35(5):321-8
pubmed: 20395703
Neuroendocrinology. 2020;110(11-12):950-958
pubmed: 31711058
Crit Rev Oncol Hematol. 2009 Sep;71(3):199-213
pubmed: 19362010
Gut. 2012 Jan;61(1):6-32
pubmed: 22052063
Discov Med. 2012 Jul;14(74):71-81
pubmed: 22846204
Eur J Nucl Med Mol Imaging. 2020 Apr;47(4):881-894
pubmed: 31414209
Cancers (Basel). 2022 Jan 25;14(3):
pubmed: 35158862
CA Cancer J Clin. 2018 Nov;68(6):471-487
pubmed: 30295930
HPB (Oxford). 2010 Aug;12(6):361-79
pubmed: 20662787
Pancreas. 2017 Jan;46(1):42-47
pubmed: 27906872
Surg Clin North Am. 2019 Aug;99(4):793-814
pubmed: 31255207
Eur J Nucl Med Mol Imaging. 2007 Jul;34(7):982-93
pubmed: 17225119
Mol Imaging Biol. 2011 Jun;13(3):583-593
pubmed: 20652423
Eur J Nucl Med Mol Imaging. 2014 Oct;41(10):1825-30
pubmed: 24806111
Mol Imaging. 2014;13:1-10
pubmed: 24824963
J Med Imaging Radiat Oncol. 2012 Feb;56(1):40-7
pubmed: 22339744
Cancer Imaging. 2018 Jan 24;18(1):3
pubmed: 29361984
Surg Oncol Clin N Am. 2020 Apr;29(2):267-279
pubmed: 32151360
AJR Am J Roentgenol. 2019 Sep;213(3):683-688
pubmed: 31120789
J Nucl Med. 2021 Nov;62(11):1564-1570
pubmed: 33637589
J Formos Med Assoc. 2018 Jun;117(6):480-487
pubmed: 28735662
J Nucl Med. 2017 Jan;58(1):91-96
pubmed: 27516446
Endocr Pathol. 2022 Mar;33(1):115-154
pubmed: 35294740
Eur J Nucl Med Mol Imaging. 2013 May;40(5):800-16
pubmed: 23389427
J Nucl Med. 2016 May;57(5):708-14
pubmed: 26769865
Best Pract Res Clin Gastroenterol. 2005 Oct;19(5):753-81
pubmed: 16253899
Ann Nucl Med. 2012 Nov;26(9):738-43
pubmed: 22865406
J Nucl Med. 2020 Feb;61(2):217-221
pubmed: 31302632
Front Med (Lausanne). 2021 Nov 26;8:771912
pubmed: 34901087
Surg Clin North Am. 2017 Apr;97(2):333-343
pubmed: 28325190
Surg Today. 2020 Dec;50(12):1578-1584
pubmed: 32193632
Q J Nucl Med Mol Imaging. 2010 Feb;54(1):68-75
pubmed: 20168288
Ann Surg Oncol. 2015 Jan;22(1):164-71
pubmed: 25190113
J Nucl Med. 2020 May;61(5):678-682
pubmed: 31806774
JAMA Oncol. 2019 Jun 01;5(6):856-863
pubmed: 30920593
J Nucl Med. 2011 May;52(5):697-704
pubmed: 21498531
Eur J Nucl Med Mol Imaging. 2009 May;36(5):765-70
pubmed: 19137293
Clin Nucl Med. 2019 Oct;44(10):777-783
pubmed: 31283601
Neuroendocrinology. 2010;91(1):101-9
pubmed: 19996582
Clin Cancer Res. 2010 Feb 1;16(3):978-85
pubmed: 20103666
J Nucl Med. 2021 Sep 1;62(9):1278-1284
pubmed: 33579809
Eur J Cancer. 2016 Jul;62:132-7
pubmed: 27189322
Ann Nucl Med. 2015 Jul;29(6):512-8
pubmed: 25894056
J Nucl Med. 2022 Nov;63(11):1651-1658
pubmed: 35422442
Lancet Oncol. 2021 Aug;22(8):1115-1125
pubmed: 34246328
J Neuroendocrinol. 2022 Jun;34(6):e13139
pubmed: 35488399
Eur J Nucl Med Mol Imaging. 2014 May;41(5):856-64
pubmed: 24435773
Diagnostics (Basel). 2021 Jan 28;11(2):
pubmed: 33525712
J Nucl Med. 2010 Mar;51(3):353-9
pubmed: 20150249
Neoplasma. 2019 Jan 15;66(1):140-148
pubmed: 30509093
J Nucl Med. 2022 Jul;63(7):1027-1032
pubmed: 34772795
Ann Nucl Med. 2016 May;30(4):279-86
pubmed: 26837515
J Neuroendocrinol. 2022 Jul;34(7):e13170
pubmed: 35729738
Cancer. 2003 Feb 15;97(4):934-59
pubmed: 12569593
Interact Cardiovasc Thorac Surg. 2019 Jun 1;28(6):957-960
pubmed: 30753507
J Nucl Med. 2014 Nov;55(11):1811-7
pubmed: 25315243
Eur J Endocrinol. 2017 May;176(5):575-582
pubmed: 28289088
Eur J Hybrid Imaging. 2021 Dec 9;5(1):22
pubmed: 34881405
J Nucl Med. 2014 Aug;55(8):1260-6
pubmed: 24876204
Nat Rev Clin Oncol. 2012 Dec;9(12):712-20
pubmed: 23149896
AJR Am J Roentgenol. 2018 Aug;211(2):278-285
pubmed: 29949416
J Natl Compr Canc Netw. 2012 Jun 1;10(6):724-64
pubmed: 22679117
Eur J Nucl Med Mol Imaging. 2016 Aug;43(9):1585-92
pubmed: 26922350
Curr Treat Options Oncol. 2019 Aug 29;20(10):78
pubmed: 31468190
Cancer Sci. 2022 Jun;113(6):1930-1938
pubmed: 35271754
J Clin Endocrinol Metab. 1987 Dec;65(6):1127-34
pubmed: 2824549
Eur J Nucl Med Mol Imaging. 2013 Oct;40(11):1770-80
pubmed: 23873003
Ann Surg Oncol. 2016 Dec;23(Suppl 5):714-721
pubmed: 27638678
Cancer Imaging. 2013 Mar 05;13:63-72
pubmed: 23466785
Gastroenterology. 2018 Mar;154(4):998-1008.e1
pubmed: 29155309
J Nucl Med. 2017 May;58(5):756-761
pubmed: 28082438
Pancreas. 2019 Aug;48(7):948-952
pubmed: 31268975
Eur Urol. 2023 May;83(5):405-412
pubmed: 36935345
Abdom Imaging. 2015 Aug;40(6):1432-40
pubmed: 25820755
J Nucl Med. 2017 Jul;58(7):1054-1057
pubmed: 28153957
Theranostics. 2017 Mar 1;7(5):1149-1158
pubmed: 28435454
Am J Clin Pathol. 2015 Mar;143(3):398-404
pubmed: 25696798
Eur J Nucl Med Mol Imaging. 2015 Feb;42(2):176-85
pubmed: 25209134
Radiology. 2016 Aug;280(2):576-84
pubmed: 26909647
J Nucl Med. 2007 Apr;48(4):508-18
pubmed: 17401086
Eur J Nucl Med Mol Imaging. 2019 Oct;46(11):2244-2251
pubmed: 31350603
Surg Pathol Clin. 2019 Dec;12(4):1021-1044
pubmed: 31672292
Nucl Med Commun. 2016 Aug;37(8):874-81
pubmed: 27096719
Eur J Nucl Med Mol Imaging. 2023 Jan;50(2):525-534
pubmed: 36181533
J Nucl Med. 2009 Dec;50(12):1927-32
pubmed: 19910422
EJNMMI Res. 2021 Mar 31;11(1):33
pubmed: 33788025
AJR Am J Roentgenol. 2011 Nov;197(5):1221-8
pubmed: 22021518
Radiographics. 2015 Mar-Apr;35(2):500-16
pubmed: 25763733
World J Surg. 2014 Jun;38(6):1353-61
pubmed: 24493070
Cancer Imaging. 2006 Oct 31;6:S178-84
pubmed: 17114073
Surg Oncol Clin N Am. 2020 Apr;29(2):209-221
pubmed: 32151356
J Nucl Med. 2009 Aug;50(8):1214-21
pubmed: 19617343
Am J Nucl Med Mol Imaging. 2022 Oct 15;12(5):152-162
pubmed: 36419585
PET Clin. 2021 Jul;16(3):365-373
pubmed: 34053580
J Nucl Med. 2015 Jan;56(1):70-5
pubmed: 25500825
Eur J Nucl Med Mol Imaging. 2006 Oct;33(10):1115-22
pubmed: 16763820
Arq Bras Cir Dig. 2017 Apr-Jun;30(2):150-154
pubmed: 29257854
EJNMMI Phys. 2021 Feb 27;8(1):21
pubmed: 33638729
J Nucl Med. 2014 Feb;55(2):204-10
pubmed: 24379222
Eur Radiol. 2017 Oct;27(10):4091-4099
pubmed: 28439648
J Nucl Med. 2020 Nov;61(11):1560-1569
pubmed: 32169914
Clin Nucl Med. 2015 Mar;40(3):e183-9
pubmed: 25608152
Cancer. 2008 Jun;112(11):2447-55
pubmed: 18383518